Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | DNM1 | Q05193 | 2/20 | 0.37 |
| ▸ | KDM4A | O75164 | 1/20 | 0.36 |
| ▸ | HIF1A | Q16665 | 1/20 | 0.36 |
| ▸ | TET2 | Q6N021 | 1/20 | 0.36 |
| ▸ | DOHH | Q9BU89 | 1/20 | 0.36 |
| ▸ | LMNA | P02545 | 2/20 | 0.33 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.33 |
| ▸ | GAA | P10253 | 1/20 | 0.33 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.33 |
| ▸ | CA12 | O43570 | 1/20 | 0.33 |
| ▸ | CA1 | P00915 | 1/20 | 0.33 |
| ▸ | CA2 | P00918 | 1/20 | 0.33 |
| ▸ | CA9 | Q16790 | 1/20 | 0.33 |
| ▸ | CYP2C19 | P33261 | 2/20 | 0.32 |
| ▸ | SLC6A5 | Q9Y345 | 2/20 | 0.32 |
| ▸ | TSHR | P16473 | 2/20 | 0.32 |
| ▸ | CYP2D6 | P10635 | 2/20 | 0.32 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.32 |
| ▸ | FAAH | O00519 | 1/20 | 0.32 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Poly(Amidoamine)Dendrimer SCHEMBL13964588 | 1.00 | DNM1 (0.37) | DNM1KDM4AHIF1ATET2DOHH | |
| SCHEMBL24625968 | 0.96 | KDM4A (0.37) | DNM1KDM4AHIF1ATET2DOHH | |
| SCHEMBL10194547 | 0.96 | KDM4A (0.37) | DNM1KDM4AHIF1ATET2DOHH | |
| SCHEMBL16984940 | 0.96 | KDM4A (0.37) | DNM1KDM4AHIF1ATET2DOHH | |
| SCHEMBL12219612 | 0.94 | KDM4A (0.38) | DNM1KDM4AHIF1ATET2DOHH | |
| SCHEMBL20097272 | 0.93 | DNM1 (0.40) | DNM1KDM4AHIF1ATET2DOHH | |
| SCHEMBL16509435 | 0.92 | KDM4A (0.40) | DNM1KDM4AHIF1ATET2DOHH | |
| SCHEMBL13374199 | 0.92 | KDM4A (0.36) | DNM1KDM4AHIF1ATET2DOHH | |
| SCHEMBL22732475 | 0.92 | DNM1 (0.37) | DNM1KDM4AHIF1ATET2DOHH | |
| SCHEMBL16917814 | 0.91 | DNM1 (0.39) | DNM1KDM4AHIF1ATET2DOHH |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 71 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-119391223-B | Preparation method of engraving gravure printing ink | 谷口油墨（烟台）有限公司 | 2025-03-04 | — | — | CN | claimed |
| CN-119391223-A | Preparation method of engraving gravure printing ink | 谷口油墨（烟台）有限公司 | 2025-02-07 | — | — | CN | claimed |
| CN-117384456-A | Multivalent bond-bonded gel and preparation method and application thereof | 苏州科技大学 | 2024-01-12 | — | — | CN | claimed |
| CN-115160501-B | Method for in-situ construction of PAMAM dendrimer porous polymer heterogeneous microspheres and application thereof | 鲁东大学 | 2023-12-08 | — | — | CN | claimed |
| CN-113304775-B | Graphene oxide supported molybdenum catalyst with surface chemically grafted, and preparation and application thereof | 沈阳药科大学 | 2023-05-26 | — | — | CN | claimed |
| CN-112245581-B | Nano material and application thereof | 南方医科大学珠江医院 | 2023-02-17 | — | — | CN | claimed |
| CN-117384456-B | Multivalent bond-bonded gel and preparation method and application thereof | 苏州科技大学 | 2026-03-13 | — | — | CN | disclosed |
| EP-4676942-A1 | PROTAMINE MOLECULES AND USES THEREOF | The University of British Columbia (CA) | 2026-01-14 | — | — | EP | disclosed |
| CN-119947699-A | Anti-carbonylation composition and use thereof | ELC 管理有限责任公司 | 2025-05-06 | — | — | CN | disclosed |
| CN-119638917-A | Aqueous dispersion of acrylic ester polymer, and preparation method and application thereof | 广州熵能创新材料股份有限公司 | 2025-03-18 | — | — | CN | disclosed |
| CN-119391223-B | Preparation method of engraving gravure printing ink | 谷口油墨（烟台）有限公司 | 2025-03-04 | — | — | CN | disclosed |
| CN-119391223-A | Preparation method of engraving gravure printing ink | 谷口油墨（烟台）有限公司 | 2025-02-07 | — | — | CN | disclosed |
| CN-118994152-A | Integrin targeting ligands and uses thereof | 箭头药业股份有限公司 | 2024-11-22 | — | — | CN | disclosed |
| US-20090221088-A1 | Fluorescent Sensor and Methods | NATIONAL SCIENCE FOUNDATION | 2009-09-03 | — | — | US | disclosed |
| US-20090111795-A1 | Multimers of Heterocyclic Compounds and Their Use | ARGENTA DISCOVERY LIMITED (GB) | 2009-04-30 | — | — | US | disclosed |
| US-20090111795-A1 | Multimers of Heterocyclic Compounds and Their Use | ARGENTA DISCOVERY LIMITED (GB) | 2009-04-30 | — | — | US | disclosed |
| US-20090105268-A1 | Dihydropyrimidone Multimers and Their Use as Human Neutrophil, Elastase Inhibitors | ARGENTA DISCOVERY LIMITED (GB) | 2009-04-23 | — | — | US | disclosed |
| US-20090105268-A1 | Dihydropyrimidone Multimers and Their Use as Human Neutrophil, Elastase Inhibitors | ARGENTA DISCOVERY LIMITED (GB) | 2009-04-23 | — | — | US | disclosed |
| WO-2006136857-A1 | DIHYDROPYRIMIDONE MULTIMERS AND THEIR USE AS HUMAN NEUTROPHIL ELASTASE INHIBITORS | ARGENTA DISCOVERY LIMITED (GB) | 2006-12-28 | — | — | WO | disclosed |
| WO-2006082412-A2 | MULTIMERS OF PYRIMIDINONE DERIVATIVES AND THEIR USE AS HUMAN NEUTROPHIL ELASTASE INHIBITORS | ARGENTA DISCOVERY LIMITED (GB) | 2006-08-10 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20090105268-A1 | Dihydropyrimidone Multimers and Their Use as Human Neutrophil, Elastase Inhibitors | SERPINB1, ELANE, MPO | DNM1 847/4885KDM4A 2958/4885HIF1A 3004/4885 |
| US-20090111795-A1 | Multimers of Heterocyclic Compounds and Their Use | MRM1, ME2, SDHA | DNM1 1581/4885KDM4A 3421/4885HIF1A 596/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.